header
Image from OpenLibrary

Clinicopathological study and phase II clinical trial of epithelial ovarian tumors / Alfred Elias Namour ; Supervised Mostafa M. Elserafi , Nayera Anwar Abdelhamid , Ahmed M. Abdelwareth

By: Contributor(s): Material type: TextTextLanguage: eng Publication details: Cairo : Alfred Elias Namour , 2008Description: 182P. : charts , facsimiles ; 25cmOther title:
  • دراسة باثواكلينيكية ودراسة اكلينيكية من المرحلة الثانية لاورام المبيض الطلائية [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology(Surgical,Pathology,Medical) Summary: Our study was carried out in a retorspective part in including 43 patients with pathologically proven epithelial ovarian cancer having a locally advanced or a metastatic disease and a prospective part including 40 eligible patients randomized in 2 ams to receive cisplatin with cyclophosphamide or with docetaxel.In the retrospective part,patients who received Paclitaxel combinations, showed an overall response rate of 60% with a median Disease Free Survival duration of months and a median Overall Survival duration of 28 months
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.Ph.D.2008.Al.C (Browse shelf(Opens below)) Not for loan 01010110051452000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.Ph.D.2008.Al.C (Browse shelf(Opens below)) 51452.CD Not for loan 01020110051452000

Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology(Surgical,Pathology,Medical)

Our study was carried out in a retorspective part in including 43 patients with pathologically proven epithelial ovarian cancer having a locally advanced or a metastatic disease and a prospective part including 40 eligible patients randomized in 2 ams to receive cisplatin with cyclophosphamide or with docetaxel.In the retrospective part,patients who received Paclitaxel combinations, showed an overall response rate of 60% with a median Disease Free Survival duration of months and a median Overall Survival duration of 28 months

Issued also as CD

There are no comments on this title.

to post a comment.